Michael B Stokes
Overview
Explore the profile of Michael B Stokes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
1898
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Noubiap J, Nyaga U, Middeldorp M, Stokes M, Sanders P
J Cardiovasc Med (Hagerstown)
. 2024 Feb;
25(4):280-293.
PMID: 38407860
Background: New nonclinical parameters are needed to improve the current stroke risk stratification schemes for patients with atrial fibrillation. This study aimed to summarize data on potential cardiac imaging correlates...
2.
Palmer M, Royal V, Jennette J, Smith A, Liu Q, Ambruzs J, et al.
Glomerular Dis
. 2023 Nov;
3(1):248-257.
PMID: 38021464
Introduction: Cure Glomerulonephropathy (CureGN) is an observational cohort study of patients with minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), membranous nephropathy (MN), or IgA nephropathy. We developed a conventional,...
3.
Montarello N, Wong H, Jeffries A, Perkins G, Hissaria P, Stokes M, et al.
Crit Care Resusc
. 2023 Oct;
25(3):155-157.
PMID: 37876367
The use of mRNA COVID-19 vaccine can on rare occasions cause life-threatening, fulminant myopericarditis. This case report demonstrates previously reported benefit of early use of venoarterial extracorporeal membrane oxygenation mechanical...
4.
Batal I, Nasr S, Dasari S, Weins A, Vena N, Stokes M, et al.
Am J Transplant
. 2023 Oct;
24(3):498-502.
PMID: 37852577
Fibronectin glomerulopathy is a rare inherited kidney disease, characterized by abnormal accumulation of fibronectin in the glomeruli. We report an exceptional case of recurrent fibronectin glomerulopathy first diagnosed in the...
5.
Stokes M, Alicia Chan W, Worthley M, Coates P
Kidney Int
. 2023 May;
103(6):1012-1014.
PMID: 37210191
No abstract available.
6.
Batal I, Khairallah P, Weins A, Andeen N, Stokes M
Front Immunol
. 2023 Mar;
14:1124249.
PMID: 36911713
Primary focal segmental glomerulosclerosis (FSGS), typically characterized by diffuse podocyte foot process effacement and nephrotic syndrome (diffuse podocytopathy), is generally attributed to a circulating permeability factor. Primary FSGS can recur...
7.
Tu S, Wong C, Stokes M, Pitman B, Sanders P, Lau D
J Cardiol Cases
. 2023 Feb;
27(2):80-83.
PMID: 36788955
Learning Objective: This case demonstrates the feasibility of cardiac resynchronization therapy (CRT) in an orthotopic heart transplant (OHT) recipient and adds to the scarcely reported data on the utility of...
8.
Stokes M, Thoi F, Scherer D, Win K, Kaye D, Teo K, et al.
J Cardiovasc Magn Reson
. 2022 Dec;
24(1):67.
PMID: 36451214
Background: Methamphetamine-associated cardiomyopathy (MA-CMP) is an increasingly recognised aetiology of cardiomyopathy. Cardiovascular magnetic resonance (CMR) is a specialised cardiac imaging modality commonly used in assessment of cardiomyopathy. We aimed to...
9.
Valdez Imbert R, Hti Lar Seng N, Stokes M, Jim B
BMJ Case Rep
. 2022 Aug;
15(8).
PMID: 35985743
Nephropathic apolipoprotein L1 (APOL1) risk alleles (G1/G2) have been associated with focal segmental glomerulosclerosis, HIV-associated nephropathy, Systemic lupus erythematosus (SLE)-associated collapsing glomerulopathy and other glomerulonephritides. These alleles confer protection from...
10.
Mishima R, Ariyaratnam J, Pitman B, Malik V, Emami M, McNamee O, et al.
Int J Cardiol Heart Vasc
. 2022 Aug;
42:101083.
PMID: 35971520
Background: Low cardiorespiratory fitness (CRF) and obesity are related to the development and maintenance of atrial fibrillation (AF). The aim of this study was to determine the association between CRF,...